Phase II part of EORTC study 26101: The sequence of bevacizumab and lomustine in patients with first recurrence of a glioblastoma.
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Wolfgang Wick, Roger Stupp, Thierry Gorlia, Martin Bendszus, Felix Sahm, Jacoline E Bromberg, Alba Ariela Brandes, Maaike J Vos, Julien Domont, Ahmed Idbaih, Jean-Sebastien Frenel, Paul M. Clement, Michel Fabbro, Emilie Le Rhun, François Dubois, Davide Musmeci, Michael Platten, Vassilis Golfinopoulos, Martin J. Van Den Bent
Institutions: Centre Hospitalier Universitaire Vaudois, European Organisation for Research and Treatment of Cancer, European Organisation for Research and Treatment of Cancer, University Hospital Heidelberg, German Cancer Research Center, Erasmus MC, Ospedale Bellaria, Medisch Centrum Haaglanden, Stichting Haaglanden Medisch Centrum, Institut Gustave Roussy, Université Pierre-et-Marie-Curie, Institut de Cancérologie de l'Ouest, Universitair Ziekenhuis Leuven, Centre Oscar Lambret, Centre Hospitalier Universitaire de Lille, Daniel den Hoed Kliniek
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2510787410